March 2026

Advancing Pandemic Preparedness: Progress, Partnerships, and Priorities for 2026

Note from the Board

Dear readers,

As we progress rapidly through the new year, we are excited to report a flurry of activity and progress from many of GloPID-R’s initiatives. Many of these are an early result of the resolutions set at last year’s general assembly. We are happy to report that this progress also reaffirms our commitment to strengthen global outbreak preparedness. We have created new working groups, Research Funding Contraction and Biosecurity, following the ongoing discussions on evolving research funding landscape.

Additionally, we are proud to announce that GloPID-R’s work to date has been highlighted in the latest International Pandemic Preparedness Secretariat report titled, ‘100 Days Mission (100DM) Implementation Report: Progress in 2025 and Priorities for 2026’. The report recognises GloPID-R’s role in advancing the integration of global and regional clinical trials networks, and cites the launch of the Global Research Improving Pandemic Preparedness (GRIPP) initiative as an innovative and coordinated funding approach to strengthen preparedness.

Lastly, we would like to thank Elizabeth Higgs from NIH/NIAD for her invaluable contribution as Board Member to GloPID-R as she stepped down at the end February. Her dedication and expertise have helped shape the direction of our initiatives, and we wish her all the best in her future endeavors.

We look forward to continuing our collaborative work with members, partners, and stakeholders throughout 2026, as we advance global preparedness and strengthen the collective response to emerging infectious threats.

Sincerely,

The GloPID-R Board

GloPID-R news

Expansion of GloPID-R Activities

Building on the outcomes, decisions, and momentum generated during GloPID-R’s General Assembly, held on 27 – 28 October, 2025 in Paris, France, the GloPID-R network has expanded the scope of its activities to further strengthen coordination among funders, support strategic alignment, and contribute to accelerating effective global outbreak response. Read more

GloPID-R Work in IPPS Report

The International Pandemic Preparedness Secretariat (IPPS) has released its ‘100 Days Mission (100DM) Implementation Report: Progress in 2025 and Priorities for 2026’. Published on 27 January 2026, the independent report assesses global progress towards the 100 Days Mission and identifies priority actions for the year ahead. Read more.

Pandemic PACTPandemic PACT at Two Years and Latest Dashboard

Two Years of Pandemic PACT

The Pandemic PACT programme is celebrating two years of advancing global funding tracking transparency and research coordination. Read more about the programme’s key achievements from the last year and upcoming milestones here.

Pandemic PACT’s Latest Dashboard

Pandemic PACT has just launched the WHO Pandemic and Epidemic Intelligence Research Funding Dashboard on their website. This is the second research agenda webpage in Pandemic PACT’s series of interactive data dashboards, which allows users to explore funding across priority areas in global health research. Read more.

Member news

Coalition for Epidemic Preparedness Innovations (CEPI)

The launch of CEPI 3.0

CEPI has recently launched its next five-year strategy, CEPI 3.0 (2027-2031). At its heart, CEPI 3.0 prioritises the 100 Days Mission and to achieve this, CEPI 3.0 will aim to strengthen vaccine development across the pathogens and viral families most likely to spark new outbreaks, advance platform technologies that can be rapidly adapted to the unknown, and weave together innovative networks for research, manufacturing and regulatory readiness so they can act as one global system when new threats emerge. 

Global Health EDCTP3 Key Updates and Milestones

Thirteenth Edition of the EDCTP Forum

The 13th edition of the European & Developing Countries Clinical Trials Partnership (EDCTP) Forum is scheduled to take place from April 5th to April 9th, 2027, at IFEMA Palacio Municipal in Madrid, Spain. 

The event will be co-hosted by the Instituto de Salud Carlos III (ISCIII) under the Spanish Ministry of Science, Innovation and Universities and the Fundación CSAI (FCSAI) under the Ministry of Health, and is co-organised by Global Health EDCTP3 and the EDCTP Association.

European Commission

Launch of BE READY and first Joint Transnational Call

After more than three years of joint preparatory efforts, the European Partnership for Pandemic Preparedness BE READY, has successfully launched in the beginning of 2026. This ten-year Partnership, which brings together 81 partners from 27 countries and the European Commission, will ensure that Europe can prepare and respond faster to emerging infectious disease threats by advancing knowledge on infectious diseases and maintaining critical research capacities between crises. The launch of BE READY was celebrated on 17 February, 2026 in Paris, bringing together over 200 participants and laying out the foundation of a fruitful future collaboration.

The 13th edition of the HBV Cure International Workshop will take place on 25th and 26th March, 2026 at the Institut Lumière in Lyon, France.
The ANRS MIE 2026 Scientific Days will be held on 1^st and 2^nd April, 2026 at the Cité Internationale Universitaire de Paris, focusing on the theme ‘Innovation to Accelerate the Response to Infectious Diseases’.

CEPIAdvancing Vaccine Innovations for Future Epidemics and Pandemics

CEPI is currently funding calls for Innovations to Prepare for Future Epidemics and Pandemics to support CEPI’s mission by advancing a broad range of vaccine innovations for pathogens with epidemic or pandemic potential, including novel pathogens capable of infecting and causing disease in humans (i.e., Disease X).

Two focus areas are open for applications under this topic. Focus Area 1 will concentrate on advancing innovative rapid-response vaccine platforms that can transform the response to a future Disease X. Focus Area 2 will emphasise on developing new vaccine candidates against Lassa fever and Disease X exemplar viral families, including paramyxoviruses, arenaviruses, coronaviruses, phenuiviruses, hantaviruses and nairoviruses.

ANRS MIESupport for Conferences and Fellowship Opportunities

Support for Conferences and Publications in Infectious Diseases

The ANRS MIE ‘Conferences and Publications 2026-2’ call for proposals supports all of the agency’s thematic areas:

All aspects of research into HIV-AIDS, sexually transmitted infections, viral hepatitis, and tuberculosis, including research into their co-infections;

Research into emerging and re-emerging infectious diseases, including arboviroses, respiratory viruses and viral haemorrhagic fevers.

Newsletter